Efficacy in social anxiety disorder (SAD)

Cipralex vs. paroxetine

After 24 weeks’ treatment, escitalopram (20 mg/day) showed superior efficacy to paroxetine (20 mg/day) in SAD.

In SAD, Cipralex showed superior efficacy over placebo on the Liebowitz Social Anxiety Scale (LSAS).

Clinical relevance of Cipralex compared with placebo was indicated by the improvement of work and social-life items of the Sheehan disability scale.

Published: 03/05/2006 Last updated: 27/07/2010

Key publications